PCK
Director Trades
| Date | Director | Value |
|---|---|---|
| 18/12/24 | J. Murray | $10,000 |
| 18/12/24 | P. Daffas | $50,000 |
| 18/12/24 | A. Davey | $19,182 |
| 18/12/24 | R. Harricks | $26,004 |
| 18/12/24 | C. Payne | $4,673 |
Company News
PainChek partners with Eldermark Software to expand US market for smartphone pain assessment app
Smartphone pain assessment app developer PainChek (ASX: PCK) has signed a new reseller and integration agreement with Minneapolis-based assisted living provider Eldermark Software to help expand its US market reach. Under the terms of the 12-month rolling agreement, Eldermark will act as a non-exclusive reseller of PainChek’s Adult phone app targeting the US long-term residential […]
PainChek prepares FDA De Novo submission for smartphone app following successful US clinical study
PainChek (ASX: PCK) has announced positive outcomes from a US clinical validation study that will allow the company to progress with a Food and Drug Administration (FDA) De Novo submission for its Adult smartphone app. The study recruited 105 nursing home residents at five sites in Iowa and New York, who were assessed for pain […]
Residential aged care sector drives strong quarterly results for PainChek
Australian medical device company PainChek (ASX: PCK) has reported a strong performance for the March quarter with much of its growth being driven by the country’s residential aged care sector. PainChek’s smartphone-based pain assessment technology was contracted to 49,811 residential aged care and dementia-specific beds during the quarter, representing a 56% increase on the 32,023 […]
PainChek grows number of licenced beds, triggers $1.25 million payment from federal government
Medical device company PainChek (ASX: PCK) confirmed it has met an important 25,000 licensed bed milestone under a $5 million grant agreement with the Australian federal government. In total, PainChek achieved more than 44,000 licensed beds, which means it is on course to scoop as much as $2 million in revenue by next year. If achieved, it […]
PainChek expands UK presence with first orders of pain assessment technology
Australian medical device company PainChek (ASX: PCK) is expanding its presence in the UK market, making its first direct sale and confirming first orders for the region. PainChek has developed a smartphone-based medical device using artificial intelligence to assess and score pain levels in real time and update medical records in the cloud. The platform […]
PainChek prepares for Australian rollout of pain assessment software in residential aged care
Healthcare innovator PainChek (ASX: PCK) has announced that it intends to partner up with Ward Medication Management (Ward MM) to deliver a state-funded national roll-out of its pain assessment technology to the Australian residential aged care market. Ward MM already has a team of clinical pharmacists working across residential aged care in Australia with PainChek’s […]
PainChek gets Singapore regulatory clearance, signs landmark deal with nation’s leading aged care provider
Australian medical device company PainChek (ASX: PCK) has advanced its international expansion strategy with receipt of a key regulatory clearance from Singapore’s Health Sciences Authority and the subsequent signing of a landmark commercial agreement with the country’s leading aged care provider Allium Healthcare Holdings. The two-year licencing deal will see PainChek’s smart phone-based pain assessment […]
PainChek partners with Australia’s largest child health research institute to trial pain app in infants
As part of its plan to expand its PainChek app to children worldwide, PainChek (ASX: PCK) has teamed up with the Melbourne Murdoch Children’s Research Institute to clinically test a version of the app for infants, with the study due to begin in days. According to PainChek, the Melbourne institute is the largest child health […]
PainChek expands internationally with Person Centred Software UK distribution agreement
PainChek (ASX: PCK) has secured a binding distribution agreement with Person Centred Software paving the way for the company to launch its pain assessment and monitoring technology into international markets. The agreement allows for Person to distribute PainChek’s namesake app to its UK client base, which comprises more than 1,200 aged care providers and over […]
Federal Government to invest $5m in PainChek’s app for dementia patients
Australian medical device company PainChek (ASX: PCK) is set to receive a $5 million grant from the Australian Federal Government to trial its pain recognition and monitoring technology in the country’s residential aged care centres. The 12-month funding package will enable the provision of a universal PainChek access licence to more than 1,000 residential aged […]